Experiment List


ID Peptide Administration Microorganism Activity
432 (IKIK)2
C. albicans Preformed biofilm
433 (IRIK) 2
C. albicans Preformed biofilm
434 1018 or IDR-1018
P. aeruginosa Formation (3-24h)
435 1018 or IDR-1018
K. pneumoniae LM21 Formation (3-24h)
436 HE1 or RI1018
P. aeruginosa Formation (3-24h)
437 HE1 or RI1018
K. pneumoniae LM21 Formation (3-24h)
438 1012 or L1012
P. aeruginosa Formation (3-24h)
439 1012 or L1012
K. pneumoniae LM21 Formation (3-24h)
440 RI1012
P. aeruginosa Formation (3-24h)
441 RI1012
K. pneumoniae LM21 Formation (3-24h)
442 1002 or L1002
P. aeruginosa Formation (3-24h)
443 1002 or L1002
K. pneumoniae LM21 Formation (3-24h)
444 RI1002
P. aeruginosa Formation (3-24h)
445 RI1002
K. pneumoniae LM21 Formation (3-24h)
446 LJK1
P. aeruginosa Formation (3-24h)
447 LJK1
K. pneumoniae LM21 Formation (3-24h)
448 DJK1
P. aeruginosa Formation (3-24h)
449 DJK1
K. pneumoniae LM21 Formation (3-24h)
450 RIJK1
P. aeruginosa Formation (3-24h)
451 LJK2
P. aeruginosa Formation (3-24h)

M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com